Fischer Medical Subsidiary to Supply 250 AI-Enabled Portable X-Ray Systems to Indonesia
Fischer Medical Ventures has signed a 6.5 million dollar contract through its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited, with PT Pharmindo Rimpang Kokoh (PT Pariko). The deal covers 250 portable X-ray systems equipped with AI for deployment in Jember, Indonesia.
The units will support the region's tuberculosis screening and control programme. Deliveries will roll out in phases through March 2026 as part of a pilot led by local authorities, positioning the company as a deeper MedTech partner across Southeast Asia.
Why this matters for healthcare teams
- Access and coverage: Portable systems help reach patients outside tertiary centers-community clinics, mobile vans, and hard-to-reach areas.
- AI-supported triage: Computer-assisted analysis can flag probable TB on chest X-rays, standardize reads, and prioritize confirmatory testing under clinical protocols. See WHO guidance on screening and CAD use for TB here.
- Throughput and workforce: Useful where radiologists are scarce, enabling supervised workflows run by trained frontline staff while maintaining oversight.
Deployment and workflow notes
- Phased rollout to March 2026: Plan for site readiness, fleet management, uptime SLAs, and spare parts/consumables to avoid screening gaps.
- Connectivity: Confirm DICOM/PACS integration, secure data transfer, and offline-to-online sync for mobile sites.
- Data governance: Use clear consent, de-identification, and retention practices aligned with local privacy requirements and public health reporting needs.
- Clinical oversight: Set thresholds for AI alerts, define escalation to radiology review, and ensure confirmatory diagnostics per national TB program protocols.
Procurement checklist
- Total cost of ownership: Include service contracts, AI licensing, software updates, detector care, and radiation safety compliance.
- Training: Plan for initial onboarding, periodic refreshers, and competency tracking for operators and reviewers.
- Performance metrics: Monitor screening yield, case detection, turnaround times, and cost per screen to guide scale-up decisions.
Company performance
In its latest quarterly results, Fischer Medical Ventures reported a net profit of 84 lakh rupees for the September quarter, reversing a loss in the same period last year. Revenue grew 64% year on year, supported by stronger demand for imaging and diagnostic solutions.
What to watch next
- Outcomes from the Jember pilot: screening coverage, case detection, and time to treatment initiation.
- Scalability across Indonesia based on operational performance and health impact.
- Evolving interoperability and regulatory expectations for AI-enabled radiology tools in public health settings.
If your hospital is building internal AI skills for imaging and diagnostics, explore practical training by role here.
Your membership also unlocks:
